Moreover, treatment of wildtype mice with a GABAA-R-specific antagonist significantly increased the cytotoxic activity of tumor-infiltrating CD8+ T cells and inflammatory marker expression in tumor-associated macrophages. The gene discussed is CD8A; the disease is neoplasm.